Rare diseases
Investigational molecules
Locations
Hegenheimermattweg 91, 4123
Research activity includes insomnia disorder, with attention to sleep maintenance and daytime functioning in people affected by persistent sleep disruption. The portfolio also includes sleep-related studies in pediatric and adolescent populations, as well as cases where insomnia occurs alongside nocturia.
The therapeutic focus extends across adult and younger age groups, reflecting interest in sleep regulation and related quality-of-life burdens.
Idorsia Pharmaceuticals Ltd. runs clinical trials in conditions such as Fabry's disease, Insomnia, Progressive multiple sclerosis, Vitiligo, among others.
Clinical trials run by this sponsor – those enrolling participants first.
The Netherlands
France
Czechia
BulgariaBulgaria
Austria
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
